Antibody persistence following administration of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines at 12–24 months of age and safety and immunog...

por Mangarule, S, Palkar, S, Mitra, M, Ravi, MD, Singh, R, Moureau, A, Jayanth, MV, Patel, DM, Ravinuthala, S, Patnaik, BN, Jordanov, E, Noriega, F
Publicado 2022

Safety and immunogenicity of a hexavalent DTwP-IPV-HB-PRP∼T vaccine versus separate DTwP-HB-PRP∼T and IPV vaccines in healthy infants in India

por Mangarule, S., Palkar, S., Mitra, M., Ravi, M.D., Dubey, A.P., Moureau, A., Jayanth, M.V., Patel, D.M., Ravinuthala, S., Jagga, S.R., Patnaik, B.N., Jordanov, E., Noriega, F.
Publicado 2022

Lot-to-lot consistency of a hexavalent DTwP-IPV-HB-PRP∼T vaccine and non-inferiority to separate DTwP-HB-PRP∼T and IPV antigen-matching vaccines at 6–8, 10–12, and 14–16 weeks of a...

por Mangarule, S, Prashanth, S, Kawade, A, Ravi, MD, Padmavathi, IV, Palkar, S, Tripathi, VN, Singh, R, Maurya, M, Mitra, M, Shetty, RS, Kompithra, RZ, Dhaded, SM, Epari, V, Moureau, A, Jayanth, MV, Varghese, K, Ravinuthala, S, Kukian, D, Patnaik, BN, Noriega, F
Publicado 2022